Thyrocare Technologies Ltd

Thyrocare Tech. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Thyrocare Technologies Ltd

₹ 966 -1.31%
22 May 3:24 p.m.
thyrocare.com BSE: 539871 NSE: THYROCARE
About

Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

Key Points

Business Segments
1) Diagnostic Testing Services (92% in FY25 vs 94% in FY22): [1] [2] The company is one of the leading Pan-India diagnostic chains, offering a range of tests focused on early disease detection and health management. It provides 929 tests and 288 profiles, including 43 wellness packages under the “Aarogyam” brand. It processes 3 Bn investigations annually and can process 10 Bn annually. [3] [4]

Website BSE NSE
  • Market Cap ₹ 5,120 Cr.
  • Current Price ₹ 966
  • High / Low ₹ 1,055 / 571
  • Stock P/E 53.5
  • Book Value ₹ 101
  • Dividend Yield 1.85 %
  • ROCE 27.6 %
  • ROE 18.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 139%

Cons

  • Stock is trading at 9.49 times its book value
  • The company has delivered a poor sales growth of 9.56% over past five years.
  • Promoters have pledged 100% of their holding.
  • Working capital days have increased from 48.9 days to 81.9 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
123 119 125 117 125 124 136 123 141 144 163 153 174
86 85 96 91 102 90 100 92 108 101 114 112 118
Operating Profit 37 34 30 26 23 33 37 31 34 42 49 40 56
OPM % 30% 28% 24% 22% 18% 27% 27% 25% 24% 29% 30% 26% 32%
2 1 1 1 2 0 2 2 3 3 2 4 5
Interest 1 1 1 1 1 1 1 1 1 1 1 0 1
Depreciation 9 8 8 9 9 9 9 11 10 9 10 15 12
Profit before tax 29 27 22 18 15 24 28 21 25 35 40 28 48
Tax % 31% 24% 35% 28% 33% 31% 28% 28% 23% 28% 27% 32% 54%
20 20 14 13 10 17 20 15 19 25 30 19 22
EPS in Rs 3.85 3.80 2.70 2.39 1.88 3.16 3.83 2.81 3.63 4.75 5.59 3.60 4.14
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
150 180 235 298 332 370 401 474 562 486 524 633
81 109 140 182 193 222 233 304 330 371 388 446
Operating Profit 69 71 95 115 139 148 168 171 232 115 136 187
OPM % 46% 40% 40% 39% 42% 40% 42% 36% 41% 24% 26% 30%
7 13 6 -16 21 14 -35 12 7 5 6 13
Interest 0 0 1 0 0 0 1 1 3 5 5 3
Depreciation 6 11 11 12 12 14 20 21 28 34 39 47
Profit before tax 69 73 89 87 148 147 112 161 207 81 98 151
Tax % 33% 33% 34% 46% 35% 35% 29% 26% 27% 30% 28% 37%
46 49 59 47 96 95 79 120 152 57 71 96
EPS in Rs 42.28 9.75 10.94 8.69 17.87 18.04 15.01 22.65 28.74 10.76 13.43 18.07
Dividend Payout % 0% 157% 91% 115% 56% 111% 33% 110% 52% 167% 134% 116%
Compounded Sales Growth
10 Years: 13%
5 Years: 10%
3 Years: 4%
TTM: 21%
Compounded Profit Growth
10 Years: 7%
5 Years: -2%
3 Years: -14%
TTM: 39%
Stock Price CAGR
10 Years: %
5 Years: 13%
3 Years: 15%
1 Year: 56%
Return on Equity
10 Years: 20%
5 Years: 20%
3 Years: 14%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 11 51 54 54 54 53 53 53 53 53 53 53
Reserves 195 229 322 364 400 403 325 393 468 468 461 484
25 0 0 0 0 0 9 10 21 21 39 23
14 14 39 26 31 32 55 73 55 70 68 116
Total Liabilities 246 293 414 444 485 488 442 528 597 612 620 676
87 83 93 89 103 108 112 119 149 157 159 158
CWIP 6 6 1 2 0 1 4 8 2 1 1 14
Investments 119 162 266 299 315 289 239 274 259 274 291 284
33 42 55 54 68 89 88 127 186 180 169 221
Total Assets 246 293 414 444 485 488 442 528 597 612 620 676

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
46 36 67 89 112 97 136 111 106 120 155 191
-52 -21 -19 -40 -48 -3 27 -53 -12 -32 -80 -55
0 -23 -45 -48 -65 -96 -163 -58 -87 -88 -84 -124
Net Cash Flow -6 -7 3 1 -1 -3 1 0 6 1 -9 12

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 12 9 11 7 10 11 14 34 60 63 28 40
Inventory Days 54 47 54 64 66 54 60 50 54 63 106 93
Days Payable 13 5 8 4 23 19 62 48 30 52 83 141
Cash Conversion Cycle 53 51 57 68 53 46 12 37 84 74 51 -9
Working Capital Days 22 52 15 28 11 4 -9 9 49 39 25 82
ROCE % 33% 27% 27% 29% 33% 31% 36% 37% 41% 15% 18% 28%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
71.18% 71.14% 71.14% 71.14% 71.14% 71.14% 71.11% 71.11% 71.11% 71.11% 71.06% 71.06%
12.82% 10.42% 10.13% 9.99% 3.44% 3.46% 3.35% 2.90% 2.49% 1.93% 2.77% 2.41%
7.15% 9.14% 8.68% 8.45% 13.46% 13.33% 13.89% 14.88% 14.89% 14.79% 14.68% 14.97%
8.85% 9.29% 10.04% 10.40% 11.95% 12.08% 11.64% 11.11% 11.49% 12.15% 11.49% 11.57%
No. of Shareholders 66,43171,41275,82274,38676,29272,00068,84464,82361,63659,37756,66657,403

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls